Overview
Prenatal Testing Research Study: Prenatal Genetic Screening for Pregnant Individuals
Every pregnancy journey comes with enough uncertainty, and genetic screening can help detect powerful information to inform decisions and aid in planning for the future. The CONNECTOR study involves three prenatal screening tests: Foresight®, Prequel, and FirstGene®. This study is looking to understand how a single screen with multiple results in a single report is different from multiple tests with multiple reports.
About the Study
The sponsor is looking to understand the clinical experience for their new product. During pregnancy, there are two main genetic screens. One looks to see if parents could pass down certain health conditions, and the other looks to see if the baby may have certain health conditions. We want to make genetic screening easier for you and your family.
Who Can Join
- Pregnant people of legal age to consent.
- Pregnant at least 10 weeks (Consent can be signed before 10 weeks)
- Individuals whose healthcare provider determines the need to undergo genetic prenatal screening.
- Interested parties who meet inclusion criteria as evaluated by study staff.
- NOT pregnant with twins or triples
- Egg Donor was NOT used for pregnancy
*Additional criteria may apply
Not sure if you qualify?
A member of our study team will review your medical history and medications with you to determine if this study may be a good fit.
What to Expect
Study Duration:
Your participation may involve up to two visits.
Study Visits:
Visit 1 is a blood draw performed during routine prenatal care. Visit 2 (Optional) is a buccal (cheek) swab collected from your newborn after birth.
Procedures:
There is only one blood draw performed as part of this study. The total volume of blood collected is approximately 50mL, about 3.5 tablespoons.
Results:
Test results are usually available within 14 days after the sample is received. Your provider will receive your results and be in contact with you to share them.